Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Squamous Cell
  • Neoplasm Staging
  • Penile Neoplasms
  • Risk Assessment
  • SEER Program

abstract

  • The CSM rate was highest in T1G3 patients and appears to justify ILND. Conversely, the CSM rate was lowest in T1G1 patients, which justifies active surveillance in this patient subset. A moderate CSM rate at 5 years was recorded for T1G2 patients, which brings into question the benefits of ILND.

publication date

  • April 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2012.11505.x

PubMed ID

  • 23057865

Additional Document Info

start page

  • E174

end page

  • 9

volume

  • 111

number

  • 4 B